Status: Not yet recruiting
TAVIS Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease
To collect information about the management of symptomatic severe Aortic Stenosis (AS) and Aortic Regurgitation (AR) using transcatheter aortic valve replacement (TAVI).
Participants needed: 600
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: JenaValve Technology, Inc.Updated: Jan 11, 2023Locations: 3Duration: 5 Years
Eligibility criteria
Patients who have signed ICF and are indicated by their doctors to be treated wi... [+4]
Patients who have known hypersensitivity or contraindication to Nitinol (titaniu... [+7]